Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04441112 · ClinicalTrials.gov registry record · Phase 2
Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial
A Phase 2 study of Arthritis Knee and Arthritis of Hip, sponsored by Saint Alphonsus Regional Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT04441112 is a Phase 2 study of Arthritis Knee and Arthritis of Hip that has completed, run by Saint Alphonsus Regional Medical Center. The registered enrollment target is 120 participants, above the 58-participant average among 3 other Arthritis Knee trials with a reported enrollment target (107% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04441112, a Phase 2 study of Arthritis Knee and Arthritis of Hip, has completed, sponsored by Saint Alphonsus Regional Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Clinicians commonly utilize intraarticular injections to treat symptomatic primary arthritis. Steroid injections are common yet have immune-modulating effects and can alter gene expression which may delay definitive arthroplasty and further damage cartilage. Non-steroidal anti-inflammatory (NSAID) injections may offer a safer profile due to their differing mechanism of action; however, there is a relative dearth of information regarding their efficacy. This non-inferiority study compares the effectiveness of triamcinolone versus ketorolac in treating symptoms of moderate to advanced primary osteoarthritis of the hip and knee.
Conditions Studied
Interventions
- DRUG Ketorolac Intraarticular Injection
- DRUG Triamcinolone Intraarticular Injection
Study Locations (1)
Idaho
- Saint Alphonsus Regional Medical Center - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2018-05-20 |
| Est. Completion | 2019-08-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04441112
The ClinicalTrials.gov registry entry for NCT04441112 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 58-participant average among 3 other Arthritis Knee trials with a reported enrollment target (107% higher). The listed sponsor is Saint Alphonsus Regional Medical Center, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Arthritis Knee appearing as the primary indexed condition, and to 2 interventions - of which Ketorolac Intraarticular Injection is the first listed.
NCT04441112 reports 1 study location spanning 1 distinct geographic area - top geographies include Idaho.
Frequently Asked Questions
What is clinical trial NCT04441112 about?
NCT04441112 is a clinical study titled "Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial". Clinicians commonly utilize intraarticular injections to treat symptomatic primary arthritis. Steroid injections are common yet have immune-modulating effects and can alter gene expression which may delay definitive arthroplasty and further damage cartilage. Non-steroidal anti-inflammatory (NSAID) i...
What is the current status of trial NCT04441112?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2018-05-20. Estimated completion is 2019-08-20.
What conditions does trial NCT04441112 study?
This clinical trial studies the following conditions: Arthritis Knee, Arthritis of Hip.
What interventions are being tested in trial NCT04441112?
The interventions under investigation include: Ketorolac Intraarticular Injection (DRUG), Triamcinolone Intraarticular Injection (DRUG).
Who is sponsoring clinical trial NCT04441112?
This trial is sponsored by Saint Alphonsus Regional Medical Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04441112 being conducted?
This trial has 1 study location across Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthritis Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Developing an Opioid Taper Intervention Before Total Joint Arthroplasty
RECRUITING · NA
-
Functional Recovery After Total Knee Arthroplasty
RECRUITING
-
Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.